Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Oct;7(5):297-306.
doi: 10.1016/s1479-666x(09)80008-5.

High mobility group A: a novel biomarker and therapeutic target in pancreatic adenocarcinoma

Affiliations
Review

High mobility group A: a novel biomarker and therapeutic target in pancreatic adenocarcinoma

S S Liau et al. Surgeon. 2009 Oct.

Abstract

High mobility group A1 (HMGA1) proteins are architectural transcriptional factors that are over-expressed in a wide range of human malignancies. Recently published evidence suggests HMGA1 is a promising candidate biomarker and therapeutic target in pancreatic cancer. This review summarises data implicating HMGA1 as an important mediator of progression in human cancer and in pancreatic cancer.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Overview of the pancreatic cancer TMA stained with H&E (A) and HMGA1 immunostaining (B). Magnified view (X100) of HMGA1 immunostaining in: (C) normal pancreas (HMGA1-negative), (D) pancreatic adenocarcinoma (HMGA1-negative), (E) Pancreatic adenocarcinoma (HMGA1-positive). F) A high power magnification (X400) of HMGA1-positive cancer section showing intense nuclear staining for HMGA1 G) Survivals of HMGA1-negative patients were compared with HMGA1-positive patients using Kaplan Meier analysis with log-rank test (P=0.0028). Adapted from Liau et al, Cancer 2008;113(2): 302–314, with permission of Wiley-Liss, Inc., a subsidiary of John Wiley & Sons, Inc. Copyright 2008 American Cancer Society.
Fig. 2
Fig. 2
Schematic diagram summarising the roles and mediators of HMGA1 in pancreatic adenocarcinoma

Similar articles

Cited by

References

    1. CancerStats. http//:info.cancerresearchuk.org/cancerstats.
    1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56(2):106–30. - PubMed
    1. CancerStats. http//:info.cancerresearchuk.org/cancerstats.
    1. American Cancer Society. Cancer facts and figures 2007. 2007. http://www.cancer.org/docroot/CRI/CRI_2_1x.asp?dt=34.
    1. Bramhall SR, Allum WH, Jones AG, et al. Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg. 1995;82(1):111–15. - PubMed

Publication types

LinkOut - more resources